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Objective: The aim of this work is to establish the human metacarpal as a new whole joint surface early-
stage osteoarthritis (OA) model that enables comparisons of articular cartilage and subchondral bone
through high resolution contrast-enhanced CT (CECT) imaging, mechanical testing, and biochemical
analysis.
Design: The fourth metacarpal was obtained from 12 human cadaveric donors and baseline mCT imaging
was followed by indentation testing. The samples were then immersed in anionic (Ioxaglate) and cationic
(CA4þ) iodinated contrast agent solutions followed by CECT. Cartilage GAG content and distribution was
measured using the 1,9 dimethylmethylene blue (DMMB) assay and Safranin-O histology staining. Linear
regression was performed to compare cartilage and subchondral bone properties.
Results: Strong and signiﬁcant positive correlations were observed between CA4þ CECT attenuation and
both GAG content (R2 ¼ 0.86) and equilibrium modulus (R2 ¼ 0.84), while correlations using Ioxaglate
were insigniﬁcant (R2  0.24, P > 0.05). Subchondral bone plate (SBP) thickness negatively and signiﬁ-
cantly correlated with SBP mineral density (R2 ¼ 0.49). Cartilage GAG content signiﬁcantly correlated
with several trabecular bone properties, including positive correlations with bone volume fraction (%BV/
TV, R2 ¼ 0.67), trabecular number (Tb.N, R2 ¼ 0.60), and trabecular thickness (R2 ¼ 0.42), and negative
relationships with structural model index (SMI, R2 ¼ 0.78) and trabecular spacing (Tb.Sp, R2 ¼ 0.56).
Similarly, equilibrium modulus correlated positively with %BV/TV (R2 ¼ 0.50), Tb.N (R2 ¼ 0.59) and
negatively with Tb.Sp (R2 ¼ 0.55) and SMI (R2 ¼ 0.60).
Conclusion: This study establishes the human metacarpal as a new early-stage OA model suitable for
rapid, high resolution CECT imaging, mechanical testing, and biochemical analysis of the cartilage and
subchondral bone, and for examining their inter-relationships.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.M.W. Grinstaff, Departments
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The study of joint diseases using ex vivo tissue models, pre-
clinical animal models, and clinical trials is key to advancing the
diagnosis and treatment of degenerative diseases, such as osteo-
arthritis (OA). Because OA is a disease affecting both cartilage and
bone, the simultaneous investigation of changes in subchondral
bone and cartilage is required, particularly in the early stages of the
disease. For example, the reduction in the glycosaminoglycan
(GAG) content in cartilage is a hallmark of early OA. Likewise
trabecular microfractures, which are present in the subchondraltd. All rights reserved.
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OA initiation through localized remodeling and vascular invasion2.
Moreover, therapeutic studies3,4 and investigations into both hy-
draulic conductance5 and subchondral-cartilage transport6 suggest
that changes in the subchondral bone plate (SBP) as well as
trabecular network are essential to understanding the pathogen-
esis of OA. Given the complexity and difﬁculty of measuring early-
stage OA cartilage and bone changes in patients or live animals, an
appropriate ex vivo cartilage-bone model would be beneﬁcial for
further studying the relationships between the properties of both
tissues in early disease.
Excised articular cartilage discs or osteochondral plugs are
routinely used ex vivo to study cartilage functional properties
(e.g., compressive stiffness)7e12 and are commonly employed for
ex vivo imaging studies, including delayed Gadolinium-Enhanced
MRI of Cartilage (dGEMRIC)13e15 and contrast-enhanced
computed tomography (CECT)9,10,16e18. However, these ex vivo
tissue models suffer from one or more of the following limita-
tions. First, while cartilage discs and plugs possess advantageous
geometries for high-resolution imaging and mechanical testing,
they do not recapitulate the native boundary conditions of the
cartilage and subchondral bone. Speciﬁcally, the exposed,
circumferential edge created during extraction alters the me-
chanics and mass transfer of ﬂuid and biomolecules in and out of
the cartilage. Further, with cartilage discs, the subchondral bone
plate and trabecular network are removed, prohibiting the
analysis of the cartilage-subchondral bone relationships. Second,
if the samples are not extracted from human cadavers, the tissue
may not adequately represent the biochemical composition and
mechanical properties7 of human tissue, particularly in disease.
Finally, the cartilage tissue is often degraded using enzymes to
simulate an early-stage OA degenerated state, yet the pattern of
tissue degradation does not often reﬂect the diseased tissue
state9,10. Therefore, more appropriate models for studying carti-
lage and subchondral bone changes present in joint diseases are
warranted.
The human metacarpal contains a small, intact, hemispherical,
nearly axi-symmetric cartilage surface that is ideal for high-
resolution imaging and mechanical testing. The underlying sub-
chondral bone is also a suitable size for high-resolution imaging,
thereby preventing the need for damaging the bone during sample
extraction or disrupting the cartilage-subchondral bone interface e
thus facilitating the simultaneous analysis of subchondral bone and
cartilage. Furthermore, OA commonly occurs in human ﬁngers2,19,
including the metacarpophalangeal joint (MCPJ)2,19, which obviates
the need for artiﬁcial cartilage degradation9,10. Hence, the human
metacarpal presents a cartilage surface with an ideal geometry for
testing with native boundary conditions and a natural range of
cartilage and bone health.
Both dGEMRIC13 and CECT9,10,20,21 enable effective estimation of
cartilage GAG content, however MRI is limited in its ability to
examine bony changes. Therefore, we sought to use CECT imaging
as method to examine the relationships between common cartilage
and bone properties towards the development of the metacarpal as
a new model for early-stage OA. Although previous publications
showcase dGEMRIC for clinical examination of MCPJ cartilage22e24,
and a novel nanoparticle CT contrast agent reﬂected GAG distri-
bution in metacarpal cartilage25, no previous imaging reports
directly examine the relationships between cartilage GAG content
and mechanical properties with bony changes in the metacarpal.
Herein, we propose the human metacarpal as an appropriate
ex vivo model for the study of early OA by demonstrating the re-
lationships between cartilage CECT attenuation, GAG content and
distribution, compressive modulus, and subchondral bone proper-
ties using CECT imaging.Method
Material/Specimen preparation
The fourth MCPJ was dissected from 12 human cadaver hands
(12 donors, no reported hand pathology, 50% male, mean age:
66.8 yrs, age range: 47e80 yrs, purchased from Medcure, Inc,
Portland, OR) and frozen. Details of sample selection (including
Outerbridge scoring), cadaveric patient demographic, and perti-
nent medical history are available in the Supplementary
Information (SI). Each intact joint was thawed, all surrounding
soft tissue was removed, the joints were disarticulated, and the
cartilage surfaces were rinsed 3x in saline. GIBCO AntieAnti stock
solution (Invitrogen, Grand Island, NY), 5 mM of EDTA (Sigma, St.
Louis, MO), and benzamidine HCl (Sigma B6506, St. Louis, MO)
were included in all solutions exposed to the cartilage to prevent
cartilage degradation. To facilitate easier gripping during imaging
and mechanical testing, the metacarpal diaphyses were embedded
in polymethylmethacrylate (PMMA) bone cement (Harry J. Bos-
worth Company, Skokie, IL).
Indentation compressive modulus (E) testing
Sequential transaxial mCT slices were acquired at an isotropic
voxel resolution of 36 mm, 70-kVp tube voltage, 113-mAmp current,
and 300-ms integration time for all samples (mCT40, Scanco Med-
ical AG, Brüttisellen, Switzerland)10. The baseline mCT data were
converted to DICOM format (Scanco Medical) before post-
processing analysis (Analyze™, AnalyzeDirect, Overland Park, KS).
The mean cartilage thickness at the indentation testing was
determined (Analyze), and the cartilage of each sample was eval-
uated using a standard, 4-step indentation testing procedurewith a
1-mm indenter (Enduratec 3230, BOSE, Eden Prairie, MN) (see SI)26.
The compressive modulus (E) was computed by ﬁtting a linear
regression line to the resulting equilibrium stress-strain data.
Contrast agent solutions preparation
Ioxaglate at 80 mgI/mL was prepared by diluting native Iox-
aglate (Hexabrix320, Mallinckrodt, St. Louis, MO) with deionized
water. CA4þ was synthesized as previously reported27, and the
CA4þ solution was prepared at 12 mgI/mL by dissolving the dry
compound in deionized water and pH balancing to 7.4 using 4.0 M
NaOH. Both solutions were adjusted to 400mOsm/kg using sodium
chloride to match the in situ osmolality of articular cartilage
(350e450 mOsm/kg28).
CECT imaging and analyses
Following mechanical testing the cartilage was immersed in
6 mL of Ioxaglate solution (24 h, room temperature) before CECT
scanning using the same mCT scanner and settings. The samples
were rinsed in saline (40 mL, overnight, room temperature), scan-
ned after washout, immersed in CA4þ (6 mL), and CECT scanned
again (see SI). The cartilage was segmented from the subchondral
bone using a region-growing algorithm (Analyze, see SI)10,18, and
the mean CECT attenuation was obtained by averaging the X-ray
attenuation over all transaxial mCT slices corresponding to cartilage
tissue and is reported as grayscale intensities in Hounsﬁeld Units
(HU). To negate the effect of biologic variation or trace residual
contrast agent, the cartilage CECT attenuation were normalized by
their baseline (non-enhanced) CT attenuation.
The subchondral bone plate (SBP) was segmented using the
same region-growing algorithm, and is reported as mg/cm3 hy-
droxyapatite (mgHA/cm3). The mean thickness of the SBP, and the
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baseline scan (see SI).
Determination of cartilage glycosaminoglycan (GAG) content and
distribution
After desorbing the CA4þ contrast agent, the cartilage surfaces
were bisected and the GAG content and distribution was assessed
for one side using the standard 1,9-dimethylmethylene blue
(DMMB) colorimetric assay29, while the GAG distribution of the
other side was determined using Safranin-O histological staining30
(www.ichworld.com, see SI).
Statistics
Initially, a power analysis was performed based on our previous
work with both the Ioxaglate9 and CA4þ10,31 contrast agents using
osteochondral plugs. Based on these studies, as well as other
similar cartilage investigations17,20,21,32,33, we expected linear cor-
relations between GAG content, indentation equilibrium modulus
(E), CECT attenuation, and subchondral bone properties. Addition-
ally, from our previous work, we expected to achieve correlations
with R2 0.80 for CECTattenuation vs GAG and CECTattenuation vs
E. Since there are few prior reports comparing cartilage composi-
tion and subchondral bone properties using regression, we
assumed we would achieve correlations with R2  0.60 between
cartilage and bone properties. Using this anticipated effect size
with a Type I Error of 0.05 and Power of 0.80, we found that a
minimum of 10 samples were required to achieve this correlation
strength. We selected a sample size of 12 to protect against sample
loss due to experimental error. Normality of the cartilage and boneFig. 1. Representative color maps from a central, sagittal, CECT slice for the metacarpal sa
corresponding Safranin-O stained histological section. Color scale bar indicates correspondin
the CA4þ contrast agent (top row in a & b) more clearly matches the distribution of the Sa
easier comparison with the corresponding histological sections, the middle column displayproperties was assumed and assessed using the ShapiroeWilk Test,
and this assumption was conﬁrmed for all properties (P > 0.05).
Linear regression analysis (SPSS 17.0, Chicago, IL) was applied to
examine relationships between E, CECT attenuations, GAG content,
mean Ip values, cartilage thickness, subchondral bone plate prop-
erties, and subchondral trabecular network parameters. Our anal-
ysis unit was each sample (each was statistically independent, as
they were from different donors), the coefﬁcient of determination
(R2) was used to assess the strength of the correlations (signiﬁcance
was set as two-tailed P < 0.05).Results
Cartilage CECT vs GAG distribution and content
Using the red color in Safranin-O stained histological sections as
a reference for GAG distribution, the color maps generated from
CA4þ enhanced CT scans reﬂected the GAG distribution in both
samples with high GAG content [Fig. 1(a)] and samples with low
GAG content [Fig. 1(b)] more than did color maps created from
Ioxaglate scans [Fig.1(a) and (b)]. Regarding GAG content, the CA4þ
enhanced CT attenuation strongly and signiﬁcantly correlated with
both GAG content [Fig. 2(a), R2 ¼ 0.86, P < 0.05] determined via
DMMB assay, and mean Ip value [Fig. 2(b), R2 ¼ 0.70, P < 0.05]
determined from Safranin-O stained histology sections. However,
for Ioxaglate, the CECT attenuation and GAG content were weakly
and not signiﬁcantly correlated [Fig. 2(a), R2 ¼ 0.12, P > 0.05], and
the correlation between Ioxaglate CECT attenuation and mean Ip
value was also neither strong nor signiﬁcant [Fig. 2(b), R2 ¼ 0.13,
P > 0.05].mple with a) the highest GAG content and b) the lowest GAG content, as well as the
g CECT attenuation in Hounsﬁeld Units (HU) for all CECT color maps. The distribution of
franin-O stain than does that of Ioxaglate (bottom row in a & b) for both samples. For
s a magniﬁed image of region indicated by the red box on the full-size color maps.
Fig. 2. Correlations for human metacarpal cartilage samples: CECT Attenuation (HU) vs a) GAG Content (% of cartilage wet mass) and b) mean Ip value (a measure of red pixel
density from Safranin-O stained histological sections that is indicative of GAG). c) GAG content (-) and axial rigidity (▫, GAG content multiplied by cartilage thickness) vs
indentation equilibrium modulus (E); and d) CECT attenuation vs E. For CECT attenuations, unﬁlled data points indicate the Ioxaglate data, while ﬁlled data points represent the
CA4þ data. All correlations were strong (R2  0.70) and signiﬁcant (P < 0.05), except for the correlations involving Ioxaglate (R2  0.24, P > 0.05).
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Strong positive correlations were observed between E and GAG
content as well as between E and axial rigidity: E vs GAG [Fig. 2(c),
R2 ¼ 0.80, P < 0.05] and E vs axial rigidity [Fig. 2(c), R2 ¼ 0.84,
P< 0.05]. Additionally, the CA4þ CECTattenuationwas strongly and
positively correlated with E, accounting for 88% of the variation in E
[Fig. 2(d)]. On the other hand, Ioxaglate CECT attenuations did not
strongly or signiﬁcantly correlate with E [Fig. 2(d), R2 ¼ 0.24,
P > 0.05].
Relationships between subchondral bone and cartilage properties
The correlations observed between the subchondral bone plate
and cartilage parameters are summarized in Table I. A signiﬁcant
positive correlation was noted between SBP thickness and bone
mineral density (SBP BMD) (Table I, Fig. 3(a), R2 ¼ 0.49, P < 0.05). A
negative, albeit insigniﬁcant, trend was observed between SBP
thickness and cartilage thickness (Table I, R2 ¼ 0.25, P > 0.05).
Relationships between cartilage and the subchondral trabecular
network
The strength of the correlations between cartilage and sub-
chondral trabecular network are reported in Table I. Brieﬂy, strong
positive correlations were observed between the bone volume
fraction (%BV/TV) and GAG content [Fig. 4(a), R2 ¼ 0.67, P < 0.05].
Strong negative correlations were noted between the structural
model index (SMI) and GAG content [Fig. 4(a), R2 ¼ 0.78, P < 0.05],
indicating a transition as GAG decreases from low SMI (plate-like)
towards an SMI of 3 (rod-like) trabecular morphology. The primarycomponents of the positive %BV/TV vs GAG correlation were sig-
niﬁcant positive correlations between GAG content and: trabecular
number (Tb.N) [Fig. 4(b), R2 ¼ 0.60, P < 0.05] and trabecular
thickness (Tb.Th) [Fig. 4(c), R2 ¼ 0.42, P < 0.05], and a signiﬁcant
negative correlation between trabecular spacing (Tb.Sp) and GAG
content [Fig. 4(d), R2 ¼ 0.56, P < 0.05].
As CA4þ is strongly correlated with GAG content [Fig. 2(a),
R2 ¼ 0.86, P < 0.05], there were signiﬁcant correlations, but with
weaker coefﬁcients of variation, between CA4þ attenuation and the
bone trabecular network properties (Table I). Similarly, there were
signiﬁcant correlations between several bone trabecular factors (%
BV/TV, SMI, Tb.N, Tb.Sp) and E (Table I). There were no signiﬁcant
correlations between Ioxaglate CECTattenuation and the trabecular
network properties.
Relationships between subchondral bone plate and trabecular
network
There were signiﬁcant correlations between the subchondral
trabecular network factors (%BV/TV, SMI, Tb.Th, Tb.Sp) and SBP
BMD (Table I), while therewere no signiﬁcant correlations between
those factors and SBP thickness (Table I).
Discussion
Osteoarthritis (OA) is a whole joint disease that affects both
cartilage and bone34, with the tissues undergoing progressive
degenerative changes including cartilage GAG depletion, sub-
chondral bone plate thickening and sclerosis, and increases in
trabecular network bone volume fraction. Hence, techniques that
assess both tissue types simultaneously are of signiﬁcant interest.
Table I
Coefﬁcients of variation (R2) for correlations between the measured parameters for cartilage properties, subchondral bone plate properties, and the subchondral trabecular


























GAG Content (% wet cartilage) e e 0.86* 0.12 0.33* 0.80* 0.01 0.11
Mean Ip Value (red pixel density) e 0.70* 0.13 e e e e
Mean CA4þAtten. (HU) e e 0.37* 0.88* 0.02 0.11
Mean lox Atten. (HU) e 0.01 0.24 0.25 0.10
Cartilage Thickness (mm) e 0.56* 0.25 0.05




SBP Thickness (mm) e 0.49*





Bone Volume Fraction 0.67* e 0.47* 0.06 0.09 0.50* 0.08 0.59*
Structural Model Index 0.78* e 0.57* 0.08 0.12 0.60* 0.09 0.49*
Trabecular Number (1/mm) 0.60* e 0.53* 0.05 0.26 0.59* 0.00 0.23
Trabecular Thickness (mm) 0.42* e 0.21 0.03 0.00 0.22 0.27 0.62*
Trabecular Spacing (mm) 0.56* e 0.49* 0.10 0.15 0.55* 0.01 0.44*
Connectivity Density (1/mm3) 0.23 e 0.24 0.02 0.15 0.24 0.05 0.11
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for characterizing early-stage OA, which possesses advantages over
cartilage disks and osteochondral plugs, and the utility of this
model is demonstrated for studying relationships within and be-
tween cartilage and bone properties using contrast-enhanced CT
(CECT). To contextualize and validate this new model, the results,
beginning with the cartilage ﬁndings followed by those for bone,
will be discussed in relation to previous reports. Then, the advan-
tages that CECT provides over conventional mechanical testing and
histological techniques methods will be highlighted along with a
reﬂection on the study's limitations, and suggestions for several
useful future studies.
The GAG content and distribution within articular cartilage give
rise to the tissue's compressive strength, and in early OA, GAG
depletion leads to reduced tissue compressive strength, resulting in
cartilage (and subsequent bone) erosion. The CA4þ distributions
shown for the metacarpal samples with the highest [Fig. 1(a)] and
lowest [Fig. 1(b)] GAG content qualitatively agree with Safranin-O
stained histological sections from the same regions. However,
anionic Ioxaglate did not partition with the expected inverse dis-
tribution of GAG content for either the high [Fig. 1(a)] or low
[Fig. 1(b)] GAG samples. Instead, Ioxaglate distributes uniformly
throughout both samples, althoughmore contrast agent penetrates
the low-GAG sample as predicted. These color maps agree with
previously reported contrast agent distribution patterns forFig. 3. (a) A signiﬁcant positive correlation between subchondral bone plate mineral density
vs SBP relationship for a sample with b) thick and c) thin SBP is shown. The region withinCA4þ10,31,32 and for Ioxaglate17,21,32. Additionally, the Safranin-O
stain distribution in the histological sections agrees with previous
reports for human cartilage35,36. Thus, CA4þ enhanced CT attenu-
ation reﬂects GAG distribution within human metacarpal cartilage
tissue.
In addition to mapping cartilage GAG content, the results pre-
sented in Fig. 2(a) and (b) show strong, signiﬁcant correlations
between CA4þ enhanced CT attenuation and both GAG content
(R2 ¼ 0.86) and mean Safranin-O Ip value (R2 ¼ 0.70) for the
metacarpal cartilage samples. These results are in agreement with
previous reports for bovine cartilage10,31,32, where, for example,
Lakin et al.10 reported signiﬁcant correlations between CA4þ CECT
and GAG in bovine cartilage (R2 ¼ 0.74 for native tissue and
R2 ¼ 0.87 for both healthy and GAG-depleted tissue). However, the
correlations between CECT attenuation and GAG content for Iox-
aglate are weak and not signiﬁcant (R2 ¼ 0.12 for GAG from DMMB
assay and R2 ¼ 0.13 for Safranin-O Ip value), even though signiﬁ-
cantly more contrast agent was used: 80 vs 12 mgI/mL. Bansal
et al.32 report similarly weak correlations using bovine cartilage
with low concentration of Ioxaglate (16 mgI/mL). However, stron-
ger correlations are reported when using 80 mgI/mL for healthy
and degraded bovine21 and native human17,33 knee cartilage. Dif-
ferences between the cartilage extra-cellular matrix (ECM) be-
tween articular joints subjected to varying degrees of load-bearing
has been demonstrated37. Consequently, it is possible these(SBP BMD) and SBP thickness. Representative sagittal mCT slices reﬂecting the SBP BMD
the red box has been magniﬁed to highlight this positive correlation.
Fig. 4. Correlations between the subchondral trabecular network properties and GAG content: a) bone volume fraction (-, %BV/TV) vs GAG content and structural model index (▫,
SMI) vs GAG Content, b) Trabecular Number (Tb.N) vs GAG content, c) Trabecular Thickness (Tb.Th) vs GAG content, and d) Trabecular Spacing (Tb.Sp) vs GAG content. As GAG
content declines, the %BV/TV decreases, SMI increases (transitioning from plate to rod-like trabeculae), Tb.N decreases, Tb.Th decreases and Tb.Sp increases. All correlations were
signiﬁcant (P < 0.05).
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ferences between human MCPJ and knee cartilage, and future
studies should investigate this possibility.
As shown in Fig. 2(c) and (d), the indentation equilibrium
compressive modulus (E) values strongly and positively correlate
with GAG content, as well as axial rigidity and mean CA4þ
enhanced CT attenuation (R2 ¼ 0.80, R2 ¼ 0.84, and R2 ¼ 0.88,
respectively; all P < 0.05), while E does not strongly correlate with
Ioxaglate CECT attenuation (R2 ¼ 0.24, P > 0.05). The strong cor-
relations between E and GAG content agree with previous re-
sults9,10, and since axial rigidity equals GAG content multiplied by
cartilage thickness, this strong correlation is expected. The speciﬁc
comparisons when using CA4þ are: R2 ¼ 0.90 (bovine knee)10 vs
R2 ¼ 0.88 (human metacarpal). With CA4þ, the electrostatic
attraction between the contrast agent and the negatively charged
GAGs affords high contrast agent uptake in both bovine and human
cartilage and corresponding strong, positive linear correlations
between the CECT attenuation and both GAG content and E. The
correlations between E and both the CECT attenuation and GAG
content further indicate the utility of the human metacarpal as a
model for studying the interrelationships between cartilage me-
chanical properties and biochemical composition, particularly as it
is an intact human joint surface prone to develop OA.
Since OA affects both cartilage and bone, an ideal ex vivo OA
model would enable simultaneous characterization of both the
cartilage and subchondral bone. Using the human metacarpal, we
found a signiﬁcant positive correlation between the subchondral
bone plate (SBP) thickness and the bone mineral density [BMD,
Fig. 3(a)], but no signiﬁcant correlation between the cartilage
thickness and SBP thickness or BMD (Table I). As GAG depletion
precedes cartilage volume changes, it is not surprising this trend isnot observed in our early OA model. In addition, no signiﬁcant
correlations are found between cartilage GAG content or CECT
attenuation with SBP thickness or BMD (Table I). However, signif-
icant correlations have been reported between: SBP thickness and
BMD, SBP thickness and cartilage thickness, as well as superﬁcial
Ioxaglate cartilage CECT attenuation and SBP thickness20; but this
study used young bovine tibial samples, whereas the present study
employs samples from human cadavers over a wide age range and
spectrum of early OA (demonstrated by a spectrum of GAG contents
within a low range of Outerbridge scores, see SI). Nevertheless,
CECT enables simultaneous evaluation of both cartilage and bone
properties of the human metacarpal in an intact state.
Regarding the correlation between the subchondral trabecular
network and GAG content, decreasing GAG content signiﬁcantly
correlates with decreasing bone volume fraction (composed of
decreasing trabecular number, decreasing trabecular thickness, and
increasing trabecular spacing) and increasing structural model in-
dex (transition from plate to rod-like morphology) (Fig. 4). As GAG
content strongly correlates with CA4þ CECT attenuation and E, the
correlations between these properties with trabecular character-
istics are expected and further demonstrate the utility of the hu-
man metacarpal as an appropriate early-stage OA model. These
correlations are also collaborated by results obtained from early
osteoarthritic mouse38 and rat39 studies, as well as in an early
human OA study40. The trabecular changes in our study differ from
those observed in late OA mouse41 and human models42. The
absence of these late changes in the present model may be due to
the predominance of early OA changes in this sample set, or the fact
the previous studies used weight-bearing joints, as trabecular
changes will vary temporally38,39 and depend on physiological
demands43.
Fig. 5. Representative CT images for a sample with a) the highest GAG content and b) the lowest GAG content. From a two-dimensional (2D) mCT scan (III, IV), one can construct (I,
II) a three-dimensional (3D) CECT color map (CA4þ enhanced CT scan shown), and (V, VI) a 3D reconstruction of the subchondral trabecular network. Unlike histology, which only
permits 2D sectioning along one plane and is both time-consuming and destructive, CECT enables rapid, facile, non-destructive (I, II) 3D color maps indicative of cartilage GAG
content and compressive stiffness, and (V, VI) the subchondral trabecular network, which can be visually sectioned in real-time in one to three planes simultaneously. Color scale
bar indicates corresponding CECT attenuation in Hounsﬁeld Units (HU) for all CECT color maps.
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early-stage OA model highlighted several substantial advantages of
CECT vs conventional mechanical testing and histological tech-
niques. Following contrast agent immersion, one CECT scan
(~20e30 min) rapidly and non-destructively yields an estimate of
the compressive modulus for the entire cartilage surface. In
contrast, indentation testing must be performed at multiple loca-
tions on a harvested sample's surface to generate a similar
compressive stiffness map, which requires many hours. Further-
more, the sample thickness at each testing site must be measured
to compute a compressive modulus, and this is often accomplished
with a destructive, needle-puncture technique44. Likewise, there
are also some considerable challenges associated with histology,
including: (1) irreversible sample damage due to processing
glitches; (2) loss of data due to incorrect sectioning orientation,
sample tears during sectioning, or tissue folding or dislodging
during mounting; (3) minimization of day-to-day variability in
processing and imaging to obtain quantitative results30; and (4)
repeat staining cannot be performed on tissue sections. For CECT,
the sample does not need to be processed or sectioned, reducing
the risk of sample damage and data loss, and contrast agents can be
washed out of samples, enabling repeat scanning with different
contrast agents (as performed in this study) or concentrations.
Additionally, the 2D sections obtained from histology cannot easily
be viewed in a different orientation, while CECT enables 3D re-
constructions and virtual real-time sectioning through one to three
planes simultaneously (Fig. 5). These 3D reconstructions enable
visualization of depth-wise cartilage properties as well as sub-
chondral bone morphology. CECT enables generation of both 2D
and 3D reconstructions, thus enabling visual representation and
comparison of cartilage and subchondral bone properties (Table I)
including GAG distribution, indentation equilibrium modulus,
subchondral bone mineral density, and trabecular network
conﬁguration between healthy [Fig. 5(a)] and early-stage OA
[Fig. 5(b)] metacarpal samples.
Although the metacarpal enables effective examination of both
cartilage and bone properties, particularly with CECT imaging,
there are a few limitations to this study that should be considered.
First, as this study aims to develop the metacarpal as a new model,
cartilage stiffness and GAGwere sampled at only one region. Future
studies could reﬁne the beneﬁt of using CECT and this model bycreating stiffness/GAG maps of entire metacarpal cartilage surfaces
and comparing these to the corresponding CECT attenuations.
Second, to obtain a natural sample set, a variety of patient de-
mographics were included. Hence, we did not assess the inﬂuence
of patient handedness, gender, and/or occupation, and thus, future
studies should examine these factors using this model. Finally,
comparing the mean CECT attenuation from a wider 3D volume to
four 2D histology sections can introduce variability. The DMMB
assay was used to measure the GAG content of the entire CECT
volume, and this was the primary method for determining cartilage
GAG content. The Ip value comparison was intended to demon-
strate that CECT non-destructively provides similar information
about cartilage GAG distribution as histological optical density
techniques.
In summary, the strong correlations between CECT attenuation,
compressive stiffness, GAG content, subchondral bone properties
and trabecular network factors establish the human metacarpal as
a new early-stage OA research model. Furthermore, unlike bovine
cartilage, which often requires GAG-depletion to mimic the natural
GAG loss during OA, human metacarpals from donors of various
ages provide a range of naturally-occurring GAG content within
morphologically normal (i.e., low Outerbridge score) samples -
reﬂecting a physiologic spectrum of early OA in a clinically relevant
human joint. As demonstrated, human metacarpals are suitable for
high-resolution imaging and mechanical testing without altering
the native boundary conditions for the cartilage or requiring
isolation from the bone tissue. For larger animal or human joints, it
is difﬁcult to perform high resolution imaging on the cartilage
surfaces, as the surfaces are larger than the view ﬁeld of the
scanner. Likewise, indentation testing is possible on larger intact
cartilage surfaces, but the more common practice is to core osteo-
chondral plugs for easier mechanical testing, and subsequent high-
resolution contrast-enhanced scanning. When used in conjunction
with the metacarpal model, CECT is a valuable technique to
simultaneously assess and compare two of the most crucially
affected tissues e cartilage and bone - in OA. The technique is more
rapid, reproducible, easier to use, and non-destructive compared to
common mechanical testing and histological methods for evalu-
ating cartilage health. Combining the human metacarpal ex vivo
model with CECT using CA4þ provides a new strategy for: (1) in-
vestigations into the interrelationship between cartilage and bone
B.A. Lakin et al. / Osteoarthritis and Cartilage 23 (2015) 2158e2166 2165properties in healthy and diseased states, (2) characterization of the
underlying pathology of different joint diseases, (3) evaluation of
therapies that address mechanisms of cartilage and bone wear, and
(4) further reﬁnement of the correlations between CECT attenua-
tion and key biochemical and biomechanical performance indices
that will aid in the development of future early OA imaging grading
scales for clinical use.
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